产前饮食与体育活动干预与妊娠期体重增加及妊娠结局的关联:系统综述与Meta分析
该研究系统检索MEDLINE、Embase等数据库(2017年2月1日至2020年5月31日),并与1990年至2017年2月的既往系统综述整合,纳入117项随机临床试验、共34 546名孕妇,评估产前饮食与体育活动生活方式干预与妊娠期体重增加(GWG)及母婴结局的关联。结果显示,与常规照护相比,总体生活方式干预与GWG减少(-1.15 kg;95% CI,-1.40至-0.91)、妊娠期糖尿病风险降低(OR 0.79;95% CI,0.70-0.89)及总不良母亲结局风险降低(OR 0.89;95% CI,0.84-0.94)相关。饮食干预与GWG减少(-2.63 kg;95% CI,-3.87至-1.40)较体育活动(-1.04 kg;95% CI,-1.33至-0.74)或混合干预(-0.74 kg;95% CI,-1.06至-0.43)更多。作者结论认为,产前结构化饮食与体育活动干预与GWG减少及母婴不良结局风险降低相关,支持在常规产前保健中实施此类干预。
要点
- 总体产前生活方式干预与GWG减少-1.15 kg(95% CI,-1.40至-0.91)、妊娠期糖尿病风险降低(OR 0.79;95% CI,0.70-0.89)及总不良母亲结局风险降低(OR 0.89;95% CI,0.84-0.94)相关。
- 饮食干预与GWG减少-2.63 kg(95% CI,-3.87至-1.40),大于体育活动(-1.04 kg;95% CI,-1.33至-0.74)和混合干预(-0.74 kg;95% CI,-1.06至-0.43)。
- 饮食干预与妊娠期糖尿病(OR 0.61;95% CI,0.45-0.82)、早产(OR 0.43;95% CI,0.22-0.84)、大于胎龄儿(OR 0.19;95% CI,0.08-0.47)、新生儿重症监护入院(OR 0.68;95% CI,0.48-0.95)及总不良母亲(OR 0.75;95% CI,0.61-0.92)和新生儿结局(OR 0.44;
- 体育活动与GWG减少及妊娠期糖尿病(OR 0.60;95% CI,0.47-0.75)、高血压性疾病(OR 0.66;95% CI,0.48-0.90)、剖宫产(OR 0.85;95% CI,0.75-0.95)及总不良母亲结局(OR 0.78;95% CI,0.71-0.86)风险降低相关。
- 饮食联合体育活动与GWG减少-1.35 kg(95% CI,-1.95至-0.75)及妊娠期糖尿病(OR 0.72;95% CI,0.54-0.96)和总不良母亲结局(OR 0.81;95% CI,0.69-0.95)风险降低相关;混合干预仅与GWG减少相关。
适用人群与场景
- 纳入报告GWG及母婴结局的随机临床试验中的孕妇;共117项随机临床试验、34 546名女性。
研究设计与关键结果
- 研究类型:系统综述与Meta分析(随机临床试验),共纳入117项随机临床试验、34 546名女性;检索MEDLINE、Embase、Cochrane系统综述数据库、效果评价摘要数据库、Cochrane对照试验中心注册库及卫生技术评估数据库,检索时间2017年2月1日至2020年5月31日,并与1990年至2017年2月的既往系统综述整合。
- 与常规照护相比,总体生活方式干预与GWG减少-1.15 kg(95% CI,-1.40至-0.91)、妊娠期糖尿病风险降低(OR 0.79;95% CI,0.70-0.89)及总不良母亲结局风险降低(OR 0.89;95% CI,0.84-0.94)相关。
- 与常规照护相比,饮食干预与GWG减少-2.63 kg(95% CI,-3.87至-1.40),大于体育活动(-1.04 kg;95% CI,-1.33至-0.74)和混合干预(-0.74 kg;95% CI,-1.06至-0.43)。
- 饮食干预与妊娠期糖尿病(OR 0.61;95% CI,0.45-0.82)、早产(OR 0.43;95% CI,0.22-0.84)、大于胎龄儿(OR 0.19;95% CI,0.08-0.47)、新生儿重症监护入院(OR 0.68;95% CI,0.48-0.95)、总不良母亲结局(OR 0.75;95% CI,0.61-0.92)及总不良新生儿结局(OR 0.44;95% CI,0.26-0.72)风险降低相关。
- 体育活动与GWG减少及妊娠期糖尿病(OR 0.60;95% CI,0.47-0.75)、高血压性疾病(OR 0.66;95% CI,0.48-0.90)、剖宫产(OR 0.85;95% CI,0.75-0.95)及总不良母亲结局(OR 0.78;95% CI,0.71-0.86)风险降低相关。
- 饮食联合体育活动与GWG减少-1.35 kg(95% CI,-1.95至-0.75)及妊娠期糖尿病(OR 0.72;95% CI,0.54-0.96)和总不良母亲结局(OR 0.81;95% CI,0.69-0.95)风险降低相关;混合干预仅与GWG减少相关。
证据类型、等级与局限
- 证据类型:系统综述与Meta分析(随机临床试验);作者称该研究发现了1级证据,即产前结构化饮食与体育活动生活方式干预与GWG减少及母婴不良结局风险降低相关。
对床旁实践的改变
- 作者结论认为,研究结果支持在全球常规产前保健和政策中实施此类干预。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
IMPORTANCE: Excessive gestational weight gain (GWG) is common and associated with adverse pregnancy outcomes. Antenatal lifestyle interventions limit GWG; yet benefits of different intervention types and specific maternal and neonatal outcomes are unclear.
OBJECTIVE: To evaluate the association of different types of diet and physical activity-based antenatal lifestyle interventions with GWG and maternal and neonatal outcomes.
DATA SOURCES: A 2-stage systematic literature search of MEDLINE, Embase, Cochrane Database of Systematic Reviews, Database of Abstracts of Reviews of Effects, Cochrane Central Register of Controlled Trials, and Health Technology Assessment Database was conducted from February 1, 2017, to May 31, 2020. Search results from the present study were integrated with those from a previous systematic review from 1990 to February 2017.
STUDY SELECTION: Randomized trials reporting GWG and maternal and neonatal outcomes.
DATA EXTRACTION AND SYNTHESIS: Data were extracted for random-effects meta-analyses to calculate the summary effect estimates and 95% CIs.
MAIN OUTCOMES AND MEASURES: Outcomes were clinically prioritized, with mean GWG as the primary outcome. Secondary outcomes included gestational diabetes, hypertensive disorders of pregnancy, cesarean section, preterm delivery, large or small for gestational age neonates, neonatal intensive care unit admission, or fetal death.
RESULTS: A total of 117 randomized clinical trials of antenatal lifestyle interventions (involving 34 546 women) were included. Overall lifestyle intervention was associated with reduced GWG (-1.15 kg; 95% CI, -1.40 to -0.91), risk of gestational diabetes (odds ratio [OR], 0.79; 95% CI, 0.70-0.89), and total adverse maternal outcomes (OR, 0.89; 95% CI, 0.84-0.94) vs routine care. Compared with routine care, diet was associated with less GWG (-2.63 kg; 95% CI, -3.87 to -1.40) than physical activity (-1.04 kg; 95% CI, -1.33 to -0.74) or mixed interventions (eg, unstructured lifestyle support, written information with weight monitoring, or behavioral support alone) (-0.74 kg; 95% CI, -1.06 to -0.43). Diet was associated with reduced risk of gestational diabetes (OR, 0.61; 95% CI, 0.45-0.82), preterm delivery (OR, 0.43; 95% CI, 0.22-0.84), large for gestational age neonate (OR, 0.19; 95% CI, 0.08-0.47), neonatal intensive care admission (OR, 0.68; 95% CI, 0.48-0.95), and total adverse maternal (OR, 0.75; 95% CI, 0.61-0.92) and neonatal outcomes (OR, 0.44; 95% CI, 0.26-0.72). Physical activity was associated with reduced GWG and reduced risk of gestational diabetes (OR, 0.60; 95% CI, 0.47-0.75), hypertensive disorders (OR, 0.66; 95% CI, 0.48-0.90), cesarean section (OR, 0.85; 95% CI, 0.75-0.95), and total adverse maternal outcomes (OR, 0.78; 95% CI, 0.71-0.86). Diet with physical activity was associated with reduced GWG (-1.35 kg; 95% CI, -1.95 to -0.75) and reduced risk of gestational diabetes (OR, 0.72; 95% CI, 0.54-0.96) and total adverse maternal outcomes (OR, 0.81; 95% CI, 0.69-0.95). Mixed interventions were associated with reduced GWG only.
CONCLUSIONS AND RELEVANCE: This systematic review and meta-analysis found level 1 evidence that antenatal structured diet and physical activity-based lifestyle interventions were associated with reduced GWG and lower risk of adverse maternal and neonatal outcomes. The findings support the implementation of such interventions in routine antenatal care and policy around the world.
参考来源
- Teede HJ, Bailey C, Moran LJ, et al. Association of Antenatal Diet and Physical Activity-Based Interventions With Gestational Weight Gain and Pregnancy Outcomes: A Systematic Review and Meta-analysis. JAMA Intern Med. 2022. PMID: 34928300. doi:10.1001/jamainternmed.2021.6373
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。